Enlivex Therapeutics
@EnlivexT
Followers
207
Following
0
Media
1
Statuses
3
Enlivex is a clinical-stage cell immunotherapy company, set to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy
Israel
Joined April 2019
Immunotherapy Company Enlivex Therapeutics Announces Nasdaq Listing Under Symbol “ENLV” and Closing of Private Placement of Ordinary Shares Priced at $12.25 Per Share.
2
0
4
Enlivex announces closing of $5.2 million pre-IPO mezzanine round:.
0
0
1
Allocetra's mode of action is simply elegant! Watch how it works:.
1
2
3